Incyte (INCY) Assets Average (2011 - 2026)
Incyte (INCY) reported Assets Average of $7.1 billion for Q1 2026, up 27.72% on a YoY basis from $5.6 billion in Q1 2025, and up 7.59% quarter-over-quarter from $6.6 billion in Q4 2025.
Incyte (INCY) Assets Average (2011 - 2026) Analysis & Trends
Incyte has reported Assets Average for 16 years, with the latest figure at $7.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 27.72% year-over-year to $7.1 billion; the trailing twelve-month figure through Mar 2026 stood at $7.1 billion (up 27.72% YoY), and the FY2025 full-year result was $6.2 billion, up 1.44% from the prior year.
- Assets Average for Q1 2026 stood at $7.1 billion, up from $6.6 billion in the prior quarter.
- The five-year high for Assets Average was $7.1 billion in Q1 2026, with the low at $4.8 billion in Q3 2024.
- Historically, Assets Average has averaged $5.9 billion across 5 years, with a median of $5.8 billion in 2023.
- Annual changes were most pronounced in 2022 — Assets Average surged 38.29% — and 2024, when it fell 23.2%.
- Incyte's Assets Average stood at $5.7 billion in 2022, then grew by 16.03% to $6.6 billion in 2023, then declined by 20.6% to $5.2 billion in 2024, then grew by 27.08% to $6.6 billion in 2025, then grew by 7.59% to $7.1 billion in 2026.
- The last three Assets Average figures came in at $7.1 billion (Q1 2026), $6.6 billion (Q4 2025), and $6.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 7.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 Bn |
| Dec 31, 2025 | 6.64 Bn |
| Sep 30, 2025 | 6.08 Bn |
| Jun 30, 2025 | 5.79 Bn |
| Mar 31, 2025 | 5.60 Bn |
| Dec 31, 2024 | 5.23 Bn |
| Sep 30, 2024 | 4.84 Bn |
| Jun 30, 2024 | 5.90 Bn |
| Mar 31, 2024 | 6.96 Bn |
| Dec 31, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.30 Bn |
| Jun 30, 2023 | 6.00 Bn |
| Mar 31, 2023 | 5.82 Bn |
| Dec 31, 2022 | 5.68 Bn |
| Sep 30, 2022 | 5.41 Bn |
| Jun 30, 2022 | 5.19 Bn |
| Mar 31, 2022 | 4.99 Bn |
| Dec 31, 2021 | 4.57 Bn |
| Sep 30, 2021 | 4.05 Bn |
| Jun 30, 2021 | 3.78 Bn |